Cargando…
Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties
The Notch signaling pathway is an important therapeutic target for the treatment of inflammatory diseases and cancer. We previously created ligand-specific inhibitors of Notch signaling comprised of Fc fusions to specific EGF-like repeats of the Notch1 extracellular domain, called Notch decoys, whic...
Autores principales: | Sargis, Timothy, Youn, Seock-Won, Thakkar, Krishna, Naiche, L. A., Paik, Na Yoon, Pajcini, Kostandin V., Kitajewski, Jan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119233/ https://www.ncbi.nlm.nih.gov/pubmed/36376768 http://dx.doi.org/10.1007/s10456-022-09861-6 |
Ejemplares similares
-
Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand
por: Greene, Maxwell, et al.
Publicado: (2016) -
Notch Signaling in the Bone Marrow Lymphopoietic Niche
por: Sottoriva, Kilian, et al.
Publicado: (2021) -
Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration
por: Swaminathan, Bhairavi, et al.
Publicado: (2022) -
A Notch/IL-21 signaling axis primes bone marrow T cell progenitor expansion
por: Sottoriva, Kilian, et al.
Publicado: (2022) -
Dlk1-Mediated Temporal Regulation of Notch Signaling Is Required for Differentiation of Alveolar Type II to Type I Cells during Repair
por: Finn, Johanna, et al.
Publicado: (2019)